Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |